Skip to main content
Clinical Trials/NCT00769054
NCT00769054
Completed
Phase 4

Lokal Infiltrations Analgesi Med Ropivakain 1 % Versus Placebo VED Vaginale Descensusoperationer: ET Prospektivt Randomiseret, Dobbeltblindet, Placebo- Kontrolleret Studie

Hvidovre University Hospital1 site in 1 country48 target enrollmentOctober 2008

Overview

Phase
Phase 4
Intervention
Ropivacaine
Conditions
Vaginal Prolapse
Sponsor
Hvidovre University Hospital
Enrollment
48
Locations
1
Primary Endpoint
Postoperative Pain during rest, coughing and ambulation
Status
Completed
Last Updated
15 years ago

Overview

Brief Summary

The purpose of this study is to compare systematic local infiltration with ropivacaine or placebo in patients undergoing repair of posterior vaginal wall prolapse.

The hypothesis is that LIA technique is opioid-sparing and a better postoperative treatment.

Registry
clinicaltrials.gov
Start Date
October 2008
End Date
October 2009
Last Updated
15 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Eligibility Criteria

Inclusion Criteria

  • eligible for elective repair of posterior vaginal wall prolapse
  • able to speak and understand Danish
  • able to give informed consent

Exclusion Criteria

  • alcohol or medical abuse
  • allergies to local anesthetics
  • age \< 18 yrs.
  • intolerance to opioids

Arms & Interventions

1

Local Infiltration with Ropivacaine

Intervention: Ropivacaine

2

Local Infiltration with Placebo

Intervention: Isotonic NaCl

Outcomes

Primary Outcomes

Postoperative Pain during rest, coughing and ambulation

Time Frame: ½, 1, 2, 4, 8, 12 and 24 h postoperatively

Secondary Outcomes

  • Postoperative Nausea and Vomitus(½, 1, 2, 4, 8, 12 and 24 h postoperatively)

Study Sites (1)

Loading locations...

Similar Trials